• iconNews
  • videos
  • entertainment
  • Home
  • News
    • UK News
    • US News
    • Australia
    • Ireland
    • World News
    • Weird News
    • Viral News
    • Sport
    • Technology
    • Science
    • True Crime
    • Travel
  • Entertainment
    • Celebrity
    • TV & Film
    • Netflix
    • Music
    • Gaming
    • TikTok
  • LAD Originals
    • Say Maaate to a Mate
    • Daily Ladness
    • Lad Files
    • UOKM8?
    • FreeToBe
    • Extinct
    • Citizen Reef
  • Advertise
  • Terms
  • Privacy & Cookies
  • LADbible Group
  • UNILAD
  • SPORTbible
  • GAMINGbible
  • Tyla
  • UNILAD Tech
  • FOODbible
  • License Our Content
  • About Us & Contact
  • Jobs
  • Latest
  • Topics A-Z
  • Authors
Facebook
Instagram
X
Threads
Snapchat
TikTok
YouTube

LAD Entertainment

YouTube

LAD Stories

Submit Your Content
Jaw-dropping results of three year weight loss drug study where a third of participants were given placebo

Home> News> Health

Published 13:49 29 May 2025 GMT+1

Jaw-dropping results of three year weight loss drug study where a third of participants were given placebo

They took people suffering liver problems and put them on semaglutide, the ingredient in drugs such as Ozempic and Wegovy

Joe Harker

Joe Harker

A lengthy study into the impact weight loss drugs have on other parts of the body has produced some impressive results, even in some people who didn't actually get the drug.

Recent times have seen plenty of people get into injecting themselves with semaglutide in the form of drugs like Ozempic and Wegovy, with some impressive results.

While most people buy them privately you can actually get prescribed Wegovy for weight loss on the NHS, though Ozempic is still something only diabetics can get a prescription for.

Advert

The drugs have proven that they can have a significant impact on weight loss, though they've also been shown to have other positive impacts on your health as well.

Plenty of people on these drugs will also be on them for quite a long time too, as Professor Giles Yeo previously told LADbible that many people would quickly regain the weight without the jab telling them they didn't need to each so much.

It's helpful to know what sort of impact taking these drugs can have over a longer term, and a lengthy study known as the 'ESSENCE trials' has been looking at just that, though not everyone got the actual drugs.

The test gave people semaglutide injections for years, though some people didn't get them (Getty Stock Image)
The test gave people semaglutide injections for years, though some people didn't get them (Getty Stock Image)

The study

Researchers gathered together 1,197 patients from 37 countries who were suffering from MASH, otherwise known as metabolic dysfunction-associated steatotic liver disease.

Advert

Two-thirds of the group would get a weekly injection of semaglutide at a dose of 2.4mg, which coincidentally is the maximum dose of semaglutide-based drug Wegovy, while the remaining third were on a placebo drug.

MASH is a life threatening form of liver disease caused by having too much fat in the liver, and is closely linked to obesity, type 2 diabetes and heart disease.

The long-term study wanted to see what impact semaglutide might have on it, which could mean weight loss drugs would have a similar impact.

The study was led by Professor Philip Newsome of King’s College London and Arun Sanyal of the VCU School of Medicine, and funded by Novo Nordisk which makes Ozempic and Wegovy.

The study was funded by the company that makes Ozempic and Wegovy, which both use semaglutide (Kristian Tuxen Ladegaard Berg/SOPA Images/LightRocket via Getty Images)
The study was funded by the company that makes Ozempic and Wegovy, which both use semaglutide (Kristian Tuxen Ladegaard Berg/SOPA Images/LightRocket via Getty Images)

The results

Results after the first 72 weeks of the study found that 62.9 percent of people taking semaglutide had inflammation in their liver reduced.

Advert

These are the results of the first 800 participants in the study, and researchers also found improvements in the liver fibrosis of 36.8 percent of those on the drug in the study.

Some other benefits were observed, including weight loss among the participants (which is unsurprising considering what they were taking) and other signs that their liver was working better.

However, among this group the study did record some of the common side effects of weight loss drugs including nausea, diarrhoea and vomiting.

Researchers found boosts to the liver health of the participants (Getty Stock Image)
Researchers found boosts to the liver health of the participants (Getty Stock Image)

The placebo group

Interestingly, some of the people who weren't actually on the drug themselves also had some improved liver health.

Advert

34.3 percent of people on the placebo also found their liver inflammation situation had improved and 22.4 percent improvement in liver fibrosis.

These people thought they were on semaglutide and it's interesting to note that some members of this third of the study also experienced the health benefits.

Featured Image Credit: Getty Stock Image

Topics: Health, Science

Joe Harker
Joe Harker

Joe graduated from the University of Salford with a degree in Journalism and worked for Reach before joining the LADbible Group. When not writing he enjoys the nerdier things in life like painting wargaming miniatures and chatting with other nerds on the internet. He's also spent a few years coaching fencing. Contact him via [email protected]

X

@MrJoeHarker

Advert

Advert

Advert

  • Man took Mounjaro weight loss drug for three months and shared 'astounding' impact
  • Man who took Mounjaro weight loss drug for three months admits he made 'big mistake' after 'astounding' impact
  • Inside ‘house of horrors’ where three kids were ‘held captive’ by ‘Covid syndrome’ parents for four years
  • Sharon Osbourne admits she doesn't eat 'three times a week' after huge weight loss

Choose your content:

Just now
an hour ago
3 hours ago
  • Just now

    'Suicide pod' creator slammed over latest 'kill switch' invention for dementia patients to schedule their future death

    Dr Philip Nitschke has received backlash over the proposal

    News
  • an hour ago

    Major update in Air India crash investigation as authorities identify potential cause of plane going down

    The tragedy might have been triggered by an engine problem, according to reports

    News
  • 3 hours ago

    Diddy’s disturbing act as 'freak off' sex tapes were shown in court for the first time

    The 55-year-old viewed the explicit videos privately

    News
  • 3 hours ago

    Donald Trump gives eerie ‘easy target’ threat as he ‘considers joining war on Iran’

    Donald Trump has contemplated the idea of American intervention in the Middle East crisis

    News